Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
|Articles|September 1, 2000
Supplements and Featured Publications
- HEDIS 2000: Strategies for Successful Menopause Management
- Volume 6
- Issue 14 Suppl
Appendix I: Sample of Pre-Meeting Survey Sent to Participants
Advertisement
Articles in this issue
about 26 years ago
Participating Facultyabout 26 years ago
Introductionabout 26 years ago
HEDIS Measure for the Management of Menopauseabout 26 years ago
Medical Affairs / Provider Relations Team Recommendationsabout 26 years ago
Quality Management Team Recommendationsabout 26 years ago
Pharmacy Team Recommendationsabout 26 years ago
Marketing / Member Relations Team Recommendationsabout 26 years ago
Patient Education Team RecommendationsAdvertisement
Related to this article
Machine learning prediction of procalcitonin positivity using inexpensive routine laboratory tests may reduce procalcitonin test volume and support diagnostic stewardship.
After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates did not change significantly overall but varied by region.
Greater 340B activity—measured by county-level hospital child sites and contract pharmacy arrangements—was associated with significantly higher county-level total and out-of-pocket health care spending.
The associate editor of Evidence-Based Oncology says the turnover that will follow this week's midterm election calls for renewed engagement from community oncology leaders with members of Congress, due to pressing reimbursement issues.
Medigap Plan F enrollment has declined since it was closed to new beneficiaries in 2020. The percentage of individual Medigap enrollees relative to non–dually eligible traditional Medicare beneficiaries increased from 2013-2024.
Among the therapeutic alternatives used in Medicare’s drug price negotiations, many were generics or biosimilars, and most differed in mechanistic class from the negotiated drug.
Advertisement
Advertisement
Trending on AJMC
1
NYC Marathon Death Puts Rhabdomyolysis Risk Factors in Focus
2
Hepatitis B Functional Cure Persists Off Treatment After Bepirovirsen
3
Data Show Upadacitinib Repigments Skin in Nonsegmental Vitiligo
4
EEOC Reportedly Plans to Narrow Pregnancy Accommodation Rules
5